“…Fifty microliters of blood was subjected to two rounds of red blood cell lysis with ammonium chloride before staining. Lymphocyte suspensions from blood, bone marrow (femurs and tibias from one hind leg), spleen, and thymus were counted (Z2 Coulter Counter; Beckman Coulter) and stained with a combination of the following mouse-reactive antibodies: FITCconjugated IgM (goat polyclonal; 1020-02; Southern Biotech); FITC-conjugated F4/80 (BM8); PE-conjugated IgD (11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26); PerCP-Cy5.5-conjugated TCRβ (H57-597); APC-conjugated CD8α (53-6.7), CD11b (M1/70), CD93 (AA4.1), IgM (II/41), Ly6G (RB6-8C5), NK1.1 (PK136), TER119 (TER-119; eBioscience); FITC-conjugated CD4 (GK1.5), CD23 (B3B4), HY-TCR (T3.70), PE-conjugated CD11b (M1/70), CD19 (1D3), CD21/35 (7G6), CD44 (IM7), γδ TCR (GL3), Vα2 TCR (B20.1), PerCP-Cy5.5-conjugated B220 (RA3-6B2), CD8α (53-6.7), CD19 (1D3), NK1.1 (PK136); CD44 (IM7; Horizon V500; BD); APC-conjugated CD3e (145-2C11); APCCy7-conjugated CD45.2 (104), PE-Cy7-conjugated CD19 (6D5), CD45.1 (A20; Pacific blue), and CD16/32 (93; purified; BioLegend). 7-Aminoactinomycin D (7-AAD) was purchased from eBioscience, and EdU labeling and staining were performed according to the manufacturer's instructions (Invitrogen) 4 h after a single i.p.…”